A detailed history of Meitav Dash Investments LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 3,641 shares of ABBV stock, worth $655,380. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,641
Previous 3,641 -0.0%
Holding current value
$655,380
Previous $624,000 15.22%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $15,479 - $18,076
-100 Reduced 2.67%
3,641 $624,000
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $21,415 - $24,401
134 Added 3.71%
3,741 $681,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $1.52 Million - $1.89 Million
-11,447 Reduced 76.04%
3,607 $485,000
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $1.52 Million - $1.89 Million
11,447 Added 317.36%
15,054 $2.03 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $364,127 - $419,347
-2,518 Reduced 41.11%
3,607 $574,000
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $3,221 - $3,694
24 Added 0.39%
6,125 $853,000
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $500,936 - $636,854
-3,640 Reduced 37.37%
6,101 $934,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $1.29 Million - $1.6 Million
9,741 New
9,741 $1.58 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $12.9 Million - $15.1 Million
-150,000 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $11 Million - $14.7 Million
150,000 New
150,000 $14.7 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $485,861 - $599,198
-6,241 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $199,336 - $221,599
-2,242 Reduced 26.43%
6,241 $590,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $76,402 - $90,401
-851 Reduced 9.12%
8,483 $786,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $858,821 - $1.15 Million
9,334 New
9,334 $884,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.